PowerPort Catheter Lawsuit Guide 2026 | Injuries, Claims and Compensation

The Bard PowerPort catheter lawsuit involves claims from patients who allegedly suffered serious complications after receiving implantable catheter devices used for long-term medical treatments. The lawsuits state that certain PowerPort devices experienced fractures and migration issues and developed infections after their surgical implantation, which resulted in medical conditions that required blood clot treatment, internal repairs, and extra surgical procedures.

The manufacturers of the devices failed to provide proper warnings about the devices’ risks to both doctors and patients, according to the plaintiffs. The ongoing PowerPort catheter litigation has become one of the largest medical device cases, involving an implantable port system, because new lawsuits keep being filed throughout the United States.

What Is the PowerPort Catheter Lawsuit About?

The Bard PowerPort catheter lawsuit involves claims from patients who allege they suffered serious injuries after receiving Bard PowerPort implantable port devices. The devices consist of a subcutaneous implant which connects to a catheter system for medicine and fluid transfusion directly into the patient’s vascular system.

The lawsuits state that some patients developed complications after the PowerPort catheter allegedly fractured, moved, or deteriorated inside the body. The reported issues include these two problems:

• Catheter fracture: Broken catheter pieces may travel through the bloodstream and cause internal injuries, sometimes requiring surgery for removal.
• Catheter migration: The catheter may shift or become dislodged, potentially leading to device failure or additional medical problems.
• Infections: Cracks or breakdowns in the device may allow bacteria to enter the body and cause infections.

The Bard PowerPort catheter design features created additional complications which exceeded the normal risks found in implantable ports, according to the lawsuits.

What Is the Bard PowerPort Catheter?

Bard Access Systems, which operates as a subsidiary of Becton Dickinson and Company, developed Bard PowerPort catheter as an implantable vascular access device. The device enables medical professionals to access a patient’s bloodstream multiple times for medication delivery, intravenous fluid administration, blood product transfer, and nutritional solution infusion.

The PowerPort catheter exists as an implantable device which doctors surgically insert beneath the patient’s skin as a member of the port/catheter system category. The device features design elements which support continuous usage through multiple treatment sessions without requiring fresh needle insertions into the patient’s veins.

The device consists of two fundamental components:

• Injection port: A small implanted port with a raised center, called a septum, where medical professionals insert a needle.
• Catheter: The port contains a flexible polyurethane tube which delivers medication directly into the bloodstream.

The Bard PowerPort catheter became the first implantable port that the U.S. Food and Drug Administration approved for power injection procedures, which use high-pressure injections during specific medical imaging processes. The device functions as a protective mechanism which prevents equipment breaks or operational breakdowns during these activities.

Read about the Ocean County Juvenile Detention Center Sexual Abuse Lawsuit

Bard PowerPort Catheter Lawsuit Updates

The litigation involving the Bard PowerPort catheter continues to move quickly as bellwether trials, expert rulings, and settlement discussions shape the future of the claims. Thousands of lawsuits allege that the devices caused serious complications, including infections, fractures, migration, and other injuries.

April 17, 2026 – Settlement Expectations Increase

Legal analysts believe settlement discussions may happen this year, although lower-value cases may receive smaller payouts. Plaintiffs with stronger injury claims may choose to reject settlements and continue toward trial.

April 16, 2026 – Trial Preparations Intensify

Judge Campbell ruled that Bard cannot argue the device was automatically safe simply because it received FDA 510(k) clearance. This limits one of the defense’s key strategies and keeps attention focused on the alleged injuries and device risks.

March 21, 2026 – Major Expert Witness Ruling

The court limited parts of Bard’s FDA expert testimony, preventing the expert from telling jurors that FDA clearance proved the device was safe and effective. Plaintiffs viewed this as an important victory.

February 2026 – Bellwether and Case Updates

One bellwether plaintiff passed away before trial, creating uncertainty around that case. Despite this, additional bellwether trials remain scheduled through 2027. The MDL currently includes more than 3,000 lawsuits.

January 28, 2026 – Real-World Consequences of Port Failures

Increasingly, the discussions in court have emphasized the effect of device complications on patients outside of the courtroom. A port malfunction can stop cancer treatment, necessitate emergency procedures, and lead to greater susceptibility to infections. The extra physical and emotional strains it imposes upon an already sick patient are, of course, damaging. The outcomes by themselves are enough to influence the estimation transformed for the courts to actually consider the severity of the allegations made against their devices. 

January 18, 2026 – Next Case Management Conference

Still on the MDL status calendar is a further conference on February 19, 2026, as a web meeting. The purpose of these regular status conferences is to monitor progress in discovery and handle any disagreements that are pending. Further preparation continues by both sides, with lawyers theoretically negotiating without the first day of a trial.

January 6, 2026 – Continued Increase of Cases Filed

Court documentation indicates there are over two thousand active cases on the MDL docket, with aggregate filings eclipsing that number. This growth attests to the rising applications of medical complications to implanted devices.

December 9, 2025 – Large Number of New Filings

November filings saw more than three hundred additional cases. This was one of the largest increases in the scope of the litigation to date.

November 4, 2025 – Continued Case Growth

October brought over one hundred new filings, keeping the overall case count climbing as the MDL moves closer to trial.

September 27, 2025 – Florida Plaintiff Joins Litigation

A plaintiff from Florida filed suit claiming earlier PowerPort implants led to catheter fracture and blood clot complications. Her lawsuit includes allegations involving design defects, manufacturing issues, inadequate warnings, and misrepresentation, and she seeks compensatory and punitive damages.

September 10, 2025 – Approaching Two Thousand Cases

The MDL inventory continued rising, nearing the two-thousand-case level. Monthly fluctuations appear related to filing timing rather than a change in overall direction.

August 30, 2025 – Texas Lawsuit Filed

A Texas plaintiff alleged her implanted port catheter fractured internally, causing infection and clotting problems that required corrective medical procedures and led to lasting effects.

August 20, 2025 – Bellwether Trial Calendar Confirmed

The court approved a structured timeline for early bellwether trials extending into 2026. These cases will be the first to present evidence before juries and will help both sides evaluate litigation risk.

August 1, 2025 – Limited Schedule Adjustment

Parties agreed to modify expert disclosure dates in one bellwether case due to laboratory delays involving evidence processing. The change affected only interim deadlines, leaving the broader schedule unchanged.

July 19, 2025 – First Trial Case Background

The first trial candidate centers on infection allegations following implantation for chemotherapy access. The plaintiff claims device design or manufacturing issues contributed to infection risk and that warnings were inadequate.

July 16, 2025 – First Trial Selection

The court formally identified the initial bellwether trial case and outlined additional cases to follow, signaling that courtroom proceedings are approaching.

July 2, 2025 – Characteristics of Strong Claims

Cases involving recent implants and serious complications such as fractures, migration, sepsis, or internal injuries are often considered particularly significant. Claims requiring surgical removal or emergency treatment involve more extensive medical evidence.

June 26, 2025 – Expert Disclosure Dispute

The court ordered revised summaries for several defense witnesses after determining earlier descriptions lacked the required detail, reinforcing compliance with disclosure rules.

May 6, 2025 – Guidance on Trial Case Types

The judge outlined a desired mix of infection, clotting, and fracture cases, along with varied catheter materials, to ensure early trials reflect different alleged injury patterns.

April 30, 2025 – Bellwether Selection Debate

Both sides agreed on some case categories but disagreed on how broadly early trials should reflect different injuries and device types, leaving final selection decisions to the court.

March 15, 2025 – Discovery Oversight

During a conference, the court addressed document production delays and reinforced compliance expectations while discussing discovery and preparation deadlines.

February 18, 2025 – Nevada Fracture Claim Filed

A plaintiff alleged that a port implanted in 2023 fractured internally, creating infection and clotting risks. The lawsuit asserts design and warning failures and seeks damages for medical harm.

December 31, 2024 – Deposition Scope Narrowed

The judge limited the breadth of proposed corporate deposition topics, requiring more targeted questioning tied to relevant issues.

December 20, 2024 – Anticipated Expert Testimony

Plaintiffs’ experts are expected to discuss catheter material composition and how certain additives may influence durability and infection risk.

November 26, 2024 – Estate Lawsuit Filed

An estate representative filed claims seeking compensation for medical costs and suffering linked to device complications experienced before the patient’s death.

November 25, 2024 – Case Volume Compared to Market Size

Despite widespread device use, only a portion of potential claims had entered litigation at that time, possibly due to limited awareness and diagnostic challenges.

February 23, 2024 – Notices of Death Submitted

Court filings recorded the deaths of two plaintiffs, allowing estate representatives to continue pursuing claims.

November 20, 2023 – Early Trial Planning Framework

The judge discussed procedures for selecting representative cases for focused discovery and potential early trials.

October 2, 2023 – MDL Assigned to Federal Judge

The litigation was assigned to David G. Campbell in Arizona, who began organizing proceedings.

August 12, 2023 – Federal Consolidation Ordered

A judicial panel centralized related federal lawsuits into one MDL to streamline proceedings and avoid inconsistent rulings.

July 25, 2023 – Panel Considered Centralization

The Judicial Panel on Multidistrict Litigation heard arguments about combining similar lawsuits, a step that ultimately led to MDL formation.

Which Devices Are Involved in the Port-a-Cath Lawsuit?

The lawsuits against Bard PowerPort catheter allege that patients received insufficient information about the dangers linked with specific implantable port devices. The lawsuits claim that adverse event reports created doubts about device safety, which existed before many patients suffered their first injuries.

The lawsuits name the following devices as their subject matter:

• Bard PowerPort ClearVUE Implantable Port
• Bard PowerPort ClearVUE ISP Implantable Port
• Bard PowerPort ClearVUE Slim Implantable Port
• Bard PowerPort ISP M.R.I. Implantable Port
• Bard PowerPort M.R.I. Implantable Port

Bard PowerPort catheter systems, plus all similar implantable ports, continue to hold U.S. Food and Drug Administration approval despite ongoing legal disputes that involve these devices.

Read about the Jamesburg Juvenile Detention Center Sexual Abuse Lawsuit

What Injuries or Complications Are Reported?

The users of PowerPort catheters have experienced various complications after undergoing surgical implantation. The most frequently reported complications include:

• Infection

Patients who develop infections can experience serious health complications that affect their port site and bloodstream. The infection may need either antibiotic treatment or complete device extraction for resolution.

• Catheter Fracture or Breakage

The port’s thin tubing system is vulnerable to cracking, breaking, and separation of its components. The condition requires surgical intervention because internal body damage occurs together with abdominal pain.

• Blood Clots

Some patients develop clots in the veins that contain the catheter. The blood clots cause body parts to swell and hurt, while their movement to other body areas creates dangerous health issues.

• Pain and Tissue Damage

Patients report experiencing pain at their port site along with skin irritation and damage to their underlying tissue. The device malfunctions may happen during active operation, typical operational procedures, or from improper device installation.

• Device Malfunction

The PowerPort system develops operational problems which prevent treatment delivery. This situation creates a delay in required medical treatment.

• Need for Additional Surgery

The majority of reported issues require surgical operations to either fix or extract the port catheter which increases both patient danger and time needed for recovery and medical expenses.

Who Is Eligible to File a Bard PowerPort Catheter Lawsuit?

People may be eligible to file a lawsuit involving Bard PowerPort catheter if they meet certain conditions related to the device and resulting injuries. 

You may qualify to file a claim if: 

• You had a Bard PowerPort catheter or another Bard implantable port device placed in your body. 
• The device allegedly fractured, migrated, failed, or experienced another malfunction after implantation. 
• You suffered serious injuries or medical complications linked to the device problem.

How Do You File a Bard PowerPort Lawsuit?

Individuals who think they have sustained injuries from a Bard PowerPort catheter are entitled to initiate a legal process which will grant them the right to receive compensation for their medical costs and all other damages. 

The claim process consists of these standard procedures, which people need to follow:

• Gather medical records: Collect documents which show the PowerPort catheter implantation date and diagnosis details, together with all treatment procedures, resulting complications, and any removal surgeries that were performed.
• Document your experience: Maintain a record of all your symptoms, together with the dates of your hospital visits and surgeries, and all the communication you had with doctors about the medical device.
• Speak with a PowerPort catheter attorney: Most law firms provide complimentary case assessments, which help clients understand whether their situation has potential for legal action.
• Review filing deadlines: Statutes of limitations differ across states, so people should take prompt action to safeguard their legal protections while also retaining their ability to file claims.

What Are the Expected Settlement Amounts in the PowerPort Catheter Lawsuit?

The complete lawsuits over Bard PowerPort catheter products remain unresolved as of May 2026. Litigation attorneys have projected that individual case settlements will vary between $10,000 and $1,000,000 for cases that have higher settlement values. 

The amount a person may receive depends on several factors, including the severity of injuries, the type of device malfunction, the medical treatment required, the long-term complications, and the available evidence connecting the injuries to the implant. 

Legal experts also note that future bellwether trials could play an important role in shaping possible settlement negotiations and compensation amounts. The estimates provided remain uncertain because there is no assurance of a particular payout.

Read about the Monsanto Roundup Lawsuit

What Evidence Is Being Used in These PowerPort Catheter Lawsuits?

The PowerPort catheter lawsuits use multiple evidence types to demonstrate that the device resulted in patient harm. Medical records document the complications that patients experienced after receiving PowerPort catheter implants through doctors’ charts, hospital reports, and treatment notes. The records establish a connection between health issues and the medical device.

• Imaging and Test Results

X-rays and scans, plus bloodwork, can reveal infections, clots, catheter breakage, and other physical problems that stem from the port installation. The visual and laboratory findings explain the reasons behind the system failure. 

• Expert Medical Opinions

Doctors and specialists review individual cases and explain whether the PowerPort catheter device could have caused the reported injuries. Their expert statements help the court understand complex medical matters. 

• Device Design and Testing Records

Lawsuits often include documents related to how the PowerPort catheter was designed and tested. The internal testing data, quality reviews, and research information reveal whether the device achieved safety standards before its commercial launch. 

• Manufacturer Warnings and Instructions

The plaintiffs examine all device warnings and instructions which the manufacturer included with the product. The case includes evidence that shows whether risk information existed in an incomplete, confusing, or delayed manner. 

• Adverse Event Reports

Healthcare professionals submit problem reports to health authorities which doctors use to establish risk patterns. These reports can demonstrate that issues were not isolated.

Who Can Be Held Responsible in the PowerPort Catheter Lawsuit?

The lawsuits claim the manufacturers may be responsible for:

• Continuing to market the devices despite reports of injuries and adverse events.
• Alleged design defects that made the catheter more likely to crack, fracture, or migrate.
• Failure to adequately warn doctors and patients about known risks and complications.
• Alleged manufacturing defects linked to device deterioration and failure.

Conclusion

The PowerPort catheter lawsuits continue to receive public attention because more patients report severe complications that they attribute to the device. The ongoing bellwether trials will establish a pattern which upcoming court decisions and jury verdicts will use to determine future settlements and litigation outcomes. The cases raise important questions regarding medical device safety standards and testing procedures, and the obligation of manufacturers to inform patients and healthcare providers about potential dangers.

The people who experienced PowerPort complications will keep searching for their legal options throughout the litigation process while they track new trial results, settlement talks, and regulatory changes about the device.

Read about the Camp Lejeune Water Lawsuit

Frequently Asked Questions About PowerPort Lawsuits